Phase transitions in secnidazole: Thermal stability and polymorphism studied by X-ray powder diffraction, thermal analysis and vibrational spectroscopy

Huang, 2011, Synthesis, characterization and bioactivity research of a derivative of secnidazole: 1-(2-chloropropyl)-2-methyl-5-nitro-1H-imidazole, J. Chem. Crystallogr., 41, 1360, 10.1007/s10870-011-0104-9 Khan, 2015, Improved efficiency and stability of secnidazole—an ideal delivery system, Saudi J. Biol. Sci., 22, 42, 10.1016/j.sjbs.2014.05.009 Rivera, 2000, Physico-chemical and solid-state characterization of secnidazole, IL Farmaco, 55, 700, 10.1016/S0014-827X(00)00096-3 Bakshi, 2004, ICH guidance in practice: establishment of inherent stability of secnidazole and development of a validated stability-indicating high-performance liquid chromatographic assay method, J. Pharm. Biomed. Anal., 36, 769, 10.1016/j.jpba.2004.08.008 Saffaj, 2004, Spectrophotometric determination of metronidazole and secnidazole in pharmaceutical preparations, Farmaco, 59, 843, 10.1016/j.farmac.2004.06.001 Allen, 2002, The Cambridge structural database: a quarter of a million crystal structures ans rising, Acta Crystallogr. B, 58, 10.1107/S0108768102003890 Armas, 1999, Crystal pseudopolymorphism of secnidazole bulk drug, C7H11N3O3, Powder Diffr., 14, 136, 10.1017/S0885715600010459 Giron, 2002, Solid state characterizations of pharmaceutical hydrates, J. Therm. Anal. Calorim., 68, 453, 10.1023/A:1016031517430 Giron, 2002, Applications of thermal analysis and coupled techniques in pharmaceutical industry, J. Therm. Anal. Calorim., 68, 335, 10.1023/A:1016015113795 Paudel, 2015, Raman spectroscopy in pharmaceutical product design, Adv. Drug Deliv. Rev., 89, 3, 10.1016/j.addr.2015.04.003 Hédoux, 2011, The contribution of Raman spectroscopy to the analysis of phase transformations in pharmaceutical compounds, Int. J. Pharm., 417, 17, 10.1016/j.ijpharm.2011.01.031 Ayala, 2010, Thermal stability of aripiprazole monohydrate investigated by Raman spectroscopy, Vib. Spectrosc., 54, 169, 10.1016/j.vibspec.2010.09.011 Ayala, 2008, Polymorphism incidence in commercial tablets of mebendazole: a vibrational spectroscopy investigation, J. Raman Spectrosc., 39, 1150, 10.1002/jrs.1952 Ayala, 2012, Conformational polymorphism of the antidiabetic drug chlorpropamide, J. Raman Spectrosc., 43, 263, 10.1002/jrs.3012 Ayala, 2006, Solid state characterization of olanzapine polymorphs using vibrational spectroscopy, Int. J. Pharm., 326, 69, 10.1016/j.ijpharm.2006.07.023 da Silva, 2010, Triple structural transition below room temperature in the antifilarial drug diethylcarbamazine citrate, Cryst. Growth Des., 10, 3094, 10.1021/cg100212q Polla, 2005, Thermal behaviour and stability in Olanzapine, Int. J. Pharm., 301, 33, 10.1016/j.ijpharm.2005.05.035 Ayala, 2007, Polymorphism in drugs investigated by low wavenumber Raman scattering, Vib. Spectrosc., 45, 112, 10.1016/j.vibspec.2007.06.004 Jaumot, 2015, MCR-ALS GUI 2.0: new features and applications, Chemom. Intell. Lab. Syst., 140, 1, 10.1016/j.chemolab.2014.10.003 Honorato, 2009 Burger, 1979, On the polymorphism of pharmaceuticals and other molecular crystals II, Mikrochim. Acta, 273, 10.1007/BF01197380 Pinto, 2010, Thermal compatibility studies of nitroimidazoles and excipients, J. Therm. Anal. Calorim., 102, 323, 10.1007/s10973-010-0889-3 Carvalho, 2016, Reversible solid-state hydration/dehydration of paroxetine HBr hemihydrate: structural and thermochemical studies, Cryst. Growth Des., 16, 1543, 10.1021/acs.cgd.5b01672 da Silva, 2013, The continuum in 5-fluorocytosine. Toward salt formation, Cryst. Growth Des., 13, 4315, 10.1021/cg400662n Mishra, 2009, Molecular structure and vibrational spectroscopic investigation of secnidazole using density functional theory, J. Phys. Chem. A, 113, 273, 10.1021/jp805399h